Discovery of MMP activated peptide-doxorubicin prodrugs as anti-tumor agents: Part I

被引:0
作者
Han, Wei
Jiang, XiangJun
Hu, Zilun
Graciani, Nilsa
Albright, Charles F.
Yue, Eddy
Zhang, Mingzhu
Dowling, Randine
Huang, Pearl
Oliff, Allen
Copeland, Robert A.
Trainor, George L.
Combs, Andrew P.
Seitz, Steven P.
机构
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] GlaxoSmithKline Inc, Stevenage, Herts, England
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
271-MEDI
引用
收藏
页数:2
相关论文
共 50 条
[31]   Mitotic kinesin-targeted antitumor agents: Discovery, lead optimization and anti-tumor activity of a series of novel quinazolinones as inhibitors of Kinesin Spindle Protein (KSP). [J].
Bergnes, G ;
Ha, E ;
Feng, BN ;
Smith, WW ;
Yao, B ;
Tochimoto, T ;
Lewis, EP ;
Lee, Y ;
Moody, RS ;
Finer, JT ;
Turincio, RA ;
Wood, KW ;
Sakowicz, R ;
Crompton, AM ;
Chabala, JC ;
Morgans, DJ ;
Sigal, NH ;
Sabry, JH .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 :B140-B140
[32]   De Novo Design of Efficient NIR-II-Activated Heavy-Atom-Free Type-I Photosensitizer for Anti-Tumor Photoimmunotherapy [J].
Chen, Huan ;
Wang, Yu ;
He, Zhangxin ;
Wan, Yingpeng ;
Cao, Chen ;
Lu, Ziwei ;
Gao, Yijian ;
Cui, Xiao ;
Lee, Ka-Wai ;
Tan, Ji-Hua ;
Xu, Wenchang ;
Yang, Yuliang ;
Li, Xiliang ;
Wang, Yali ;
Hou, Jianquan ;
Li, Shengliang ;
Lee, Chun-Sing .
ADVANCED MATERIALS, 2025,
[33]   MOUSE AND LARGE-ANIMAL TOXICOLOGY STUDIES OF 12 ANTI-TUMOR AGENTS - RELEVANCE TO STARTING DOSE FOR PHASE-I CLINICAL-TRIALS [J].
PENTA, JS ;
ROZENCWEIG, M ;
GUARINO, AM ;
MUGGIA, FM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 3 (02) :97-101
[34]   Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression [J].
Zhao, Jiaojiao ;
Zhang, Zhengkui ;
Xue, Yaxian ;
Wang, Guoqun ;
Cheng, Yuan ;
Pan, Yuchen ;
Zhao, Shuli ;
Hou, Yayi .
THERANOSTICS, 2018, 8 (22) :6307-6321
[35]   Activated T cells armed with anti-CD3 x anti-HER2/neu bispecific antibody I:: Anti-tumor activity and survival in SCID/Beige mice. [J].
Smith, JA ;
Davol, PA ;
Kouttab, NM ;
Rathore, R ;
Elfenbein, GJ ;
Lum, LG .
BLOOD, 2002, 100 (11) :673A-673A
[36]   Preparation and characterization of PEGylated liposomal Doxorubicin targeted with leptin-derived peptide and evaluation of their anti-tumor effects, in vitro and in vivo in mice bearing C26 colon carcinoma [J].
Shahraki, Naghmeh ;
Mehrabian, Amin ;
Amiri-Darban, Shahrazad ;
Moosavian, Seyedeh Alia ;
Jaafari, Mahmoud Reza .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2021, 200
[37]   A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity [J].
Yan, Siqi ;
Yan, Jin ;
Liu, Dan ;
Li, Xiang ;
Kang, Qianyan ;
You, Weiming ;
Zhang, Jinghua ;
Wang, Lei ;
Tian, Zhiqi ;
Lu, Wuyuan ;
Liu, Wenjia ;
He, Wangxiao .
THERANOSTICS, 2021, 11 (14) :6833-6846
[38]   A phase I study to evaluate safety, immunogenicity and anti-tumor activity of the multi-peptide vaccine IMA901 in renal cell carcinoma patients (RCC) [J].
Staehler, M. ;
Stenzl, A. ;
Dietrich, P. Y. ;
Eisen, T. ;
Haferkamp, A. ;
Beck, J. ;
Mayer, A. ;
Walter, S. ;
Singh-Jasuja, H. ;
Stief, C. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[39]   A phase I study to evaluate safety, immunogenicity and anti-tumor activity of a HER2 multi-peptide virosome vaccine in patients with metastatic breast cancer [J].
Jasinska, J. ;
Wiltschke, C. ;
Zurbriggen, R. ;
Elandt, K. ;
Braemswig, K. ;
Pehamberger, H. ;
Scheiner, O. ;
Zielinski, C. C. ;
Wiedermann, U. .
WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 :114-115
[40]   Discovery of 4,5-dihydro-benzo[g]indazole-based hydroxamic acids as HDAC3/BRD4 dual inhibitors and anti-tumor agents [J].
Li, Bo ;
Chen, Yibing ;
Wang, Siyuan ;
Jin, Bo ;
Yang, Jinyu ;
Niu, Qun ;
Hao, Guizhou ;
Wang, Ning ;
Zhang, Wenchao ;
Zhao, Linxiang ;
Wen, Jiachen ;
Liu, Dan .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 285